“Honest And Straightforward” 483 Responses May Avert Warning Letters
Executive Summary
CDER is weighing companies' responses to FDA-483 inspection reports in considering whether to issue warning letters, Center for Drug Evaluation & Research Office of Compliance Director David Horowitz said
You may also be interested in...
GMP Quality Management Systems For FDA Will Be Proposed By December
FDA expects to release a draft on improving the agency's good manufacturing practices management systems by Dec. 1
FDA GMP Dispute Resolution Guidance Allows 10 Days To Raise Objections
FDA's dispute resolution draft guidance will allow manufacturers 10 days to challenge FDA inspection findings
GMP Dispute Resolution Draft Guidance To Issue In Next Few Months
FDA expects to issue a draft guidance in the coming months on a formal dispute resolution process for scientific and technical issues that arise during inspections